Cargando…

Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock

INTRODUCTION: Recent clinical studies have shown a relationship between abnormalities in peripheral perfusion and unfavorable outcome in patients with circulatory shock. Nitroglycerin is effective in restoring alterations in microcirculatory blood flow. The aim of this study was to investigate wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Alexandre, van Genderen, Michel E, van Bommel, Jasper, Klijn, Eva, Jansem, Tim, Bakker, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229779/
https://www.ncbi.nlm.nih.gov/pubmed/24946777
http://dx.doi.org/10.1186/cc13932
_version_ 1782344166873759744
author Lima, Alexandre
van Genderen, Michel E
van Bommel, Jasper
Klijn, Eva
Jansem, Tim
Bakker, Jan
author_facet Lima, Alexandre
van Genderen, Michel E
van Bommel, Jasper
Klijn, Eva
Jansem, Tim
Bakker, Jan
author_sort Lima, Alexandre
collection PubMed
description INTRODUCTION: Recent clinical studies have shown a relationship between abnormalities in peripheral perfusion and unfavorable outcome in patients with circulatory shock. Nitroglycerin is effective in restoring alterations in microcirculatory blood flow. The aim of this study was to investigate whether nitroglycerin could correct the parameters of abnormal peripheral circulation in resuscitated circulatory shock patients. METHODS: This interventional study recruited patients who had circulatory shock and who persisted with abnormal peripheral perfusion despite normalization of global hemodynamic parameters. Nitroglycerin started at 2 mg/hour and doubled stepwise (4, 8, and 16 mg/hour) each 15 minutes until an improvement in peripheral perfusion was observed. Peripheral circulation parameters included capillary refill time (CRT), skin-temperature gradient (Tskin-diff), perfusion index (PI), and tissue oxygen saturation (StO(2)) during a reactive hyperemia test (RincStO(2)). Measurements were performed before, at the maximum dose, and after cessation of nitroglycerin infusion. Data were analyzed by using linear model for repeated measurements and are presented as mean (standard error). RESULTS: Of the 15 patients included, four patients (27%) responded with an initial nitroglycerin dose of 2 mg/hour. In all patients, nitroglycerin infusion resulted in significant changes in CRT, Tskin-diff, and PI toward normal at the maximum dose of nitroglycerin: from 9.4 (0.6) seconds to 4.8 (0.3) seconds (P <0.05), from 3.3°C (0.7°C) to 0.7°C (0.6°C) (P <0.05), and from [log] -0.5% (0.2%) to 0.7% (0.1%) (P <0.05), respectively. Similar changes in StO(2) and RincStO(2) were observed: from 75% (3.4%) to 84% (2.7%) (P <0.05) and 1.9%/second (0.08%/second) to 2.8%/second (0.05%/second) (P <0.05), respectively. The magnitude of changes in StO(2) was more pronounced for StO(2) of less than 75%: 11% versus 4%, respectively (P <0.05). CONCLUSIONS: Dose-dependent infusion of nitroglycerin reverted abnormal peripheral perfusion and poor tissue oxygenation in patients following circulatory shock resuscitation. Individual requirements of nitroglycerin dose to improve peripheral circulation vary between patients. A simple and fast physical examination of peripheral circulation at the bedside can be used to titrate nitroglycerin infusion.
format Online
Article
Text
id pubmed-4229779
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42297792014-11-14 Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock Lima, Alexandre van Genderen, Michel E van Bommel, Jasper Klijn, Eva Jansem, Tim Bakker, Jan Crit Care Research INTRODUCTION: Recent clinical studies have shown a relationship between abnormalities in peripheral perfusion and unfavorable outcome in patients with circulatory shock. Nitroglycerin is effective in restoring alterations in microcirculatory blood flow. The aim of this study was to investigate whether nitroglycerin could correct the parameters of abnormal peripheral circulation in resuscitated circulatory shock patients. METHODS: This interventional study recruited patients who had circulatory shock and who persisted with abnormal peripheral perfusion despite normalization of global hemodynamic parameters. Nitroglycerin started at 2 mg/hour and doubled stepwise (4, 8, and 16 mg/hour) each 15 minutes until an improvement in peripheral perfusion was observed. Peripheral circulation parameters included capillary refill time (CRT), skin-temperature gradient (Tskin-diff), perfusion index (PI), and tissue oxygen saturation (StO(2)) during a reactive hyperemia test (RincStO(2)). Measurements were performed before, at the maximum dose, and after cessation of nitroglycerin infusion. Data were analyzed by using linear model for repeated measurements and are presented as mean (standard error). RESULTS: Of the 15 patients included, four patients (27%) responded with an initial nitroglycerin dose of 2 mg/hour. In all patients, nitroglycerin infusion resulted in significant changes in CRT, Tskin-diff, and PI toward normal at the maximum dose of nitroglycerin: from 9.4 (0.6) seconds to 4.8 (0.3) seconds (P <0.05), from 3.3°C (0.7°C) to 0.7°C (0.6°C) (P <0.05), and from [log] -0.5% (0.2%) to 0.7% (0.1%) (P <0.05), respectively. Similar changes in StO(2) and RincStO(2) were observed: from 75% (3.4%) to 84% (2.7%) (P <0.05) and 1.9%/second (0.08%/second) to 2.8%/second (0.05%/second) (P <0.05), respectively. The magnitude of changes in StO(2) was more pronounced for StO(2) of less than 75%: 11% versus 4%, respectively (P <0.05). CONCLUSIONS: Dose-dependent infusion of nitroglycerin reverted abnormal peripheral perfusion and poor tissue oxygenation in patients following circulatory shock resuscitation. Individual requirements of nitroglycerin dose to improve peripheral circulation vary between patients. A simple and fast physical examination of peripheral circulation at the bedside can be used to titrate nitroglycerin infusion. BioMed Central 2014 2014-06-19 /pmc/articles/PMC4229779/ /pubmed/24946777 http://dx.doi.org/10.1186/cc13932 Text en Copyright © 2014 Lima et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lima, Alexandre
van Genderen, Michel E
van Bommel, Jasper
Klijn, Eva
Jansem, Tim
Bakker, Jan
Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock
title Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock
title_full Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock
title_fullStr Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock
title_full_unstemmed Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock
title_short Nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock
title_sort nitroglycerin reverts clinical manifestations of poor peripheral perfusion in patients with circulatory shock
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229779/
https://www.ncbi.nlm.nih.gov/pubmed/24946777
http://dx.doi.org/10.1186/cc13932
work_keys_str_mv AT limaalexandre nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock
AT vangenderenmichele nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock
AT vanbommeljasper nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock
AT klijneva nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock
AT jansemtim nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock
AT bakkerjan nitroglycerinrevertsclinicalmanifestationsofpoorperipheralperfusioninpatientswithcirculatoryshock